Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels

Tonghui Ma1, Yuanlin Song1, Baoxue Yang1, Anne-Marie Gillespie1, Elaine J. Carlson1, Charles J. Epstein1, A. S. Verkman1
1Departments of Medicine, Physiology, and Pediatrics, Cardiovascular Research Institute, University of California, San Francisco, CA 94143-0521

Tóm tắt

Aquaporin-3 (AQP3) is a water channel expressed at the basolateral plasma membrane of kidney collecting-duct epithelial cells. The mouse AQP3 cDNA was isolated and encodes a 292-amino acid water/glycerol-transporting glycoprotein expressed in kidney, large airways, eye, urinary bladder, skin, and gastrointestinal tract. The mouse AQP3 gene was analyzed, and AQP3 null mice were generated by targeted gene disruption. The growth and phenotype of AQP3 null mice were grossly normal except for polyuria. AQP3 deletion had little effect on AQP1 or AQP4 protein expression but decreased AQP2 protein expression particularly in renal cortex. Fluid consumption in AQP3 null mice was more than 10-fold greater than that in wild-type litter mates, and urine osmolality (<275 milliosmol) was much lower than in wild-type mice (>1,200 milliosmol). After 1-desamino-8- d -arginine-vasopressin administration or water deprivation, the AQP3 null mice were able to concentrate their urine partially to ≈30% of that in wild-type mice. Osmotic water permeability of cortical collecting-duct basolateral membrane, measured by a spatial filtering optics method, was >3-fold reduced by AQP3 deletion. To test the hypothesis that the residual concentrating ability of AQP3 null mice was due to the inner medullary collecting-duct water channel AQP4, AQP3/AQP4 double-knockout mice were generated. The double-knockout mice had greater impairment of urinary-concentrating ability than did the AQP3 single-knockout mice. Our findings establish a form of nephrogenic diabetes insipidus produced by impaired water permeability in collecting-duct basolateral membrane. Basolateral membrane aquaporins may thus provide blood-accessible targets for drug discovery of aquaretic inhibitors.

Từ khóa


Tài liệu tham khảo

T Ma, A Frigeri, H Hasegawa, A S Verkman J Biol Chem 269, 21845–21849 (1994).

K Ishibashi, S Sasaki, S Fushimi, S Uchida, M Kuwahara, H Saito, T Furukawa, K Nakajima, Y Yamaguchi, T Gojobori, et al. Proc Natl Acad Sci USA 91, 6269–6273 (1994).

M Echevarria, E E Windhager, S S Tate, G Frindt Proc Natl Acad Sci USA 91, 10997–11001 (1994).

B Yang, A S Verkman J Biol Chem 272, 16140–16146 (1997).

A K Meinild, D A Klaerke, T Zeuthen J Biol Chem 273, 32446–32451 (1998).

M Kuwahara, Y Gu, K Ishibashi, F Marumo, S Sasaki Biochemistry 36, 13973–13978 (1997).

M Echevarria, E E Windhager, G Frindt J Biol Chem 271, 25079–25082 (1996).

A Frigeri, M Gropper, D Brown, A S Verkman J Cell Sci 108, 2993–3002 (1995).

A Frigeri, M Gropper, C W Turck, A S Verkman Proc Natl Acad Sci USA 92, 4328–4331 (1995).

S Nielsen, L S King, B M Cristensen, P Agre Am J Physiol 273, C1549–C1561 (1997).

L S King, S Nielsen, P Agre Am J Physiol 273, C1541–C1548 (1997).

R Ramirez-Lorca, M L Vizuete, J L Venero, M Revuelta, J Cano, A A Ilundain, M Echevarria Pflügers Arch 438, 94–100 (1999).

N Inase, K Fushimi, K Ishibashi, S Uchida, A Ichioka, S Sasaki, F Marumo J Biol Chem 270, 17913–17916 (1995).

K Ishibashi, S Sasaki, K Fushimi, T Yamamoto, M Kuwahara, F Marumo Am J Physiol 272, F235–F241 (1997).

C A Ecelbarger, J Terris, G Frindt, M Echevarria, D Marples, S Nielsen, M A Knepper Am J Physiol 269, F663–F672 (1995).

J Terris, C A Ecelbarger, D Marples, M A Knepper, S Nielsen Am J Physiol 269, F775–F785 (1995).

T Ma, B Yang, A Gillespie, E J Carlson, C J Epstein, A S Verkman J Clin Invest 100, 957–962 (1997).

C L Chou, T Ma, B Yang, M A Knepper, A S Verkman Am J Physiol 274, C549–C554 (1998).

T Ma, B Yang, A Gillespie, E J Carlson, C J Epstein, A S Verkman J Biol Chem 273, 4296–4299 (1998).

J Schnermann, C L Chou, T Ma, T Traynor, M A Knepper, A S Verkman Proc Natl Acad Sci USA 95, 9660–9664 (1998).

C L Chou, M A Knepper, A N van Hoek, D Brown, B Yang, T Ma, A S Verkman J Clin Invest 103, 491–496 (1999).

T L Pallone, A Edwards, T Ma, E Silldorff, A S Verkman J Clin Invest 105, 2686–2692 (2000).

R Zhang, W Skach, H Hasegawa, A N van Hoek, A S Verkman J Cell Biol 120, 359–369 (1993).

T Ma, N Fukuda, Y Song, M A Matthay, A S Verkman J Clin Invest 105, 93–100 (2000).

J Farinas, M Kneen, M Moore, A S Verkman J Gen Physiol 110, 283–296 (1997).

K Strange, K R Spring J Membr Biol 96, 27–43 (1987).

B Flamion, K R Spring Am J Physiol 259, F986–F999 (1990).

R A Star J Clin Invest 86, 1172–1178 (1990).

D Marples, J Frokiaer, S Nielsen Am J Physiol 276, F331–F339 (1999).

T Ma, Y Song, A Gillespie, E J Carlson, C J Epstein, A S Verkman J Biol Chem 274, 20071–20074 (1999).

K M Madsen, C C Tisher Am J Physiol 250, F1–F15 (1986).

J Dorup J Ultrastruc Res 92, 101–118 (1985).

T Bennett, S M Gardiner J Physiol (London) 385, 35–48 (1987).

H Valtin, B R Edwards Kidney Int 31, 634–640 (1987).

B Yang, T Ma, J Y Dong, A S Verkman Hum Gene Ther 11, 567–575 (2000).